English
简体中文
Total: £ 56.28
Published Date: 2025-12-23 | Pages: 76 | Tables: 73 | Pharma & Healthcare
The global market for Tegafur,Gimeracil and Oteracil Porassium Capsules was valued at US$ 1632 million in the year 2024 and is projected to reach a revised size of US$ 11720 million by 2031, growing at a CAGR of 33.0% during the forecast period.
Tegafur,Gimeracil and Oteracil Porassium Capsules (S-1 capsules) are an oral anti-tumor medication belonging to the fluoropyrimidine class of chemotherapeutic agents. Its primary components are tegafur, gimeracil, and oteracil potassium, which work synergistically to enhance anti-cancer efficacy while reducing side effects. This drug is commonly used for the treatment of gastrointestinal cancers (such as gastric cancer and colorectal cancer) and other solid tumors.
North American market for Tegafur,Gimeracil and Oteracil Porassium Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tegafur,Gimeracil and Oteracil Porassium Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tegafur,Gimeracil and Oteracil Porassium Capsules include Taiho Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Qilu Pharmaceutical, Shandong New Era Pharmaceutical, Yangtze River Pharmaceutical Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Tegafur,Gimeracil and Oteracil Porassium Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tegafur,Gimeracil and Oteracil Porassium Capsules.
The Tegafur,Gimeracil and Oteracil Porassium Capsules market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tegafur,Gimeracil and Oteracil Porassium Capsules market comprehensively. Regional market sizes, concerning products by Type, by Channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tegafur,Gimeracil and Oteracil Porassium Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Channel, and by regions.
By Company
Taiho Pharmaceutical
Jiangsu Hengrui Pharmaceuticals
Qilu Pharmaceutical
Shandong New Era Pharmaceutical
Yangtze River Pharmaceutical Group
Segment by Type
20mg
25mg
Segment by Channel
Hospitals
Drug Stores
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Tegafur,Gimeracil and Oteracil Porassium Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Tegafur,Gimeracil and Oteracil Porassium Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Tegafur,Gimeracil and Oteracil Porassium Capsules Market Overview
1.1 Product Definition
1.2 Tegafur,Gimeracil and Oteracil Porassium Capsules by Type
1.2.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Value Comparison by Type (2024 VS 2031)
1.2.2 20mg
1.2.3 25mg
1.3 Tegafur,Gimeracil and Oteracil Porassium Capsules by Channel
1.3.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Value by Channel (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Drug Stores
1.4 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size Estimates and Forecasts
1.4.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue 2020-2031
1.4.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales 2020-2031
1.4.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tegafur,Gimeracil and Oteracil Porassium Capsules Market Competition by Manufacturers
2.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tegafur,Gimeracil and Oteracil Porassium Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tegafur,Gimeracil and Oteracil Porassium Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tegafur,Gimeracil and Oteracil Porassium Capsules, Product Type & Application
2.7 Global Key Manufacturers of Tegafur,Gimeracil and Oteracil Porassium Capsules, Date of Enter into This Industry
2.8 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Competitive Situation and Trends
2.8.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tegafur,Gimeracil and Oteracil Porassium Capsules Players Market Share by Revenue
2.8.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Scenario by Region
3.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Region: 2020-2031
3.2.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Region: 2020-2025
3.2.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Region: 2026-2031
3.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Region: 2020-2031
3.3.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Region: 2020-2025
3.3.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Region: 2026-2031
3.4 North America Tegafur,Gimeracil and Oteracil Porassium Capsules Market Facts & Figures by Country
3.4.1 North America Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2020-2031)
3.4.3 North America Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Market Facts & Figures by Country
3.5.1 Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2020-2031)
3.5.3 Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Region (2020-2031)
3.6.3 Asia Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Tegafur,Gimeracil and Oteracil Porassium Capsules Market Facts & Figures by Country
3.7.1 Latin America Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2020-2031)
3.7.3 Latin America Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Type (2020-2031)
4.1.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Type (2020-2025)
4.1.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Type (2026-2031)
4.1.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Type (2020-2031)
4.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Type (2020-2031)
4.2.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Type (2020-2025)
4.2.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Type (2026-2031)
4.2.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Type (2020-2031)
4.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Price by Type (2020-2031)
5 Segment by Channel
5.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Channel (2020-2031)
5.1.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Channel (2020-2025)
5.1.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Channel (2026-2031)
5.1.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Channel (2020-2031)
5.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Channel (2020-2031)
5.2.1 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Channel (2020-2025)
5.2.2 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Channel (2026-2031)
5.2.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Channel (2020-2031)
5.3 Global Tegafur,Gimeracil and Oteracil Porassium Capsules Price by Channel (2020-2031)
6 Key Companies Profiled
6.1 Taiho Pharmaceutical
6.1.1 Taiho Pharmaceutical Company Information
6.1.2 Taiho Pharmaceutical Description and Business Overview
6.1.3 Taiho Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Taiho Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Product Portfolio
6.1.5 Taiho Pharmaceutical Recent Developments/Updates
6.2 Jiangsu Hengrui Pharmaceuticals
6.2.1 Jiangsu Hengrui Pharmaceuticals Company Information
6.2.2 Jiangsu Hengrui Pharmaceuticals Description and Business Overview
6.2.3 Jiangsu Hengrui Pharmaceuticals Tegafur,Gimeracil and Oteracil Porassium Capsules Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Jiangsu Hengrui Pharmaceuticals Tegafur,Gimeracil and Oteracil Porassium Capsules Product Portfolio
6.2.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
6.3 Qilu Pharmaceutical
6.3.1 Qilu Pharmaceutical Company Information
6.3.2 Qilu Pharmaceutical Description and Business Overview
6.3.3 Qilu Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Qilu Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Product Portfolio
6.3.5 Qilu Pharmaceutical Recent Developments/Updates
6.4 Shandong New Era Pharmaceutical
6.4.1 Shandong New Era Pharmaceutical Company Information
6.4.2 Shandong New Era Pharmaceutical Description and Business Overview
6.4.3 Shandong New Era Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shandong New Era Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Product Portfolio
6.4.5 Shandong New Era Pharmaceutical Recent Developments/Updates
6.5 Yangtze River Pharmaceutical Group
6.5.1 Yangtze River Pharmaceutical Group Company Information
6.5.2 Yangtze River Pharmaceutical Group Description and Business Overview
6.5.3 Yangtze River Pharmaceutical Group Tegafur,Gimeracil and Oteracil Porassium Capsules Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Yangtze River Pharmaceutical Group Tegafur,Gimeracil and Oteracil Porassium Capsules Product Portfolio
6.5.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tegafur,Gimeracil and Oteracil Porassium Capsules Industry Chain Analysis
7.2 Tegafur,Gimeracil and Oteracil Porassium Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tegafur,Gimeracil and Oteracil Porassium Capsules Production Mode & Process Analysis
7.4 Tegafur,Gimeracil and Oteracil Porassium Capsules Sales and Marketing
7.4.1 Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Channels
7.4.2 Tegafur,Gimeracil and Oteracil Porassium Capsules Distributors
7.5 Tegafur,Gimeracil and Oteracil Porassium Capsules Customer Analysis
8 Tegafur,Gimeracil and Oteracil Porassium Capsules Market Dynamics
8.1 Tegafur,Gimeracil and Oteracil Porassium Capsules Industry Trends
8.2 Tegafur,Gimeracil and Oteracil Porassium Capsules Market Drivers
8.3 Tegafur,Gimeracil and Oteracil Porassium Capsules Market Challenges
8.4 Tegafur,Gimeracil and Oteracil Porassium Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Value by Channel (2024 VS 2031) & (US$ Million)
Table 3. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Competitive Situation by Manufacturers in 2024
Table 4. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales (M Units) of Key Manufacturers (2020-2025)
Table 5. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Tegafur,Gimeracil and Oteracil Porassium Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Tegafur,Gimeracil and Oteracil Porassium Capsules, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Tegafur,Gimeracil and Oteracil Porassium Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Tegafur,Gimeracil and Oteracil Porassium Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Tegafur,Gimeracil and Oteracil Porassium Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tegafur,Gimeracil and Oteracil Porassium Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tegafur,Gimeracil and Oteracil Porassium Capsules as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Region (2020-2025) & (M Units)
Table 18. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Region (2020-2025)
Table 19. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Region (2026-2031) & (M Units)
Table 20. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Region (2026-2031)
Table 21. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Region (2020-2025)
Table 23. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Region (2026-2031)
Table 25. North America Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2020-2025) & (M Units)
Table 27. North America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2026-2031) & (M Units)
Table 28. North America Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2020-2025) & (M Units)
Table 32. Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2026-2031) & (M Units)
Table 33. Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Region (2020-2025) & (M Units)
Table 37. Asia Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Region (2026-2031) & (M Units)
Table 38. Asia Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2020-2025) & (M Units)
Table 42. Latin America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2026-2031) & (M Units)
Table 43. Latin America Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2020-2025) & (M Units)
Table 47. Middle East and Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Sales by Country (2026-2031) & (M Units)
Table 48. Middle East and Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales (M Units) by Type (2020-2025)
Table 51. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales (M Units) by Type (2026-2031)
Table 52. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Type (2020-2025)
Table 53. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Type (2026-2031)
Table 54. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Type (2020-2025)
Table 57. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Type (2026-2031)
Table 58. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Price (US$/Unit) by Type (2020-2025)
Table 59. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Price (US$/Unit) by Type (2026-2031)
Table 60. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales (M Units) by Channel (2020-2025)
Table 61. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales (M Units) by Channel (2026-2031)
Table 62. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Channel (2020-2025)
Table 63. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Channel (2026-2031)
Table 64. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue (US$ Million) by Channel (2020-2025)
Table 65. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue (US$ Million) by Channel (2026-2031)
Table 66. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Channel (2020-2025)
Table 67. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Channel (2026-2031)
Table 68. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Price (US$/Unit) by Channel (2020-2025)
Table 69. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Price (US$/Unit) by Channel (2026-2031)
Table 70. Taiho Pharmaceutical Company Information
Table 71. Taiho Pharmaceutical Description and Business Overview
Table 72. Taiho Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Taiho Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Product
Table 74. Taiho Pharmaceutical Recent Developments/Updates
Table 75. Jiangsu Hengrui Pharmaceuticals Company Information
Table 76. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 77. Jiangsu Hengrui Pharmaceuticals Tegafur,Gimeracil and Oteracil Porassium Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Jiangsu Hengrui Pharmaceuticals Tegafur,Gimeracil and Oteracil Porassium Capsules Product
Table 79. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 80. Qilu Pharmaceutical Company Information
Table 81. Qilu Pharmaceutical Description and Business Overview
Table 82. Qilu Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Qilu Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Product
Table 84. Qilu Pharmaceutical Recent Developments/Updates
Table 85. Shandong New Era Pharmaceutical Company Information
Table 86. Shandong New Era Pharmaceutical Description and Business Overview
Table 87. Shandong New Era Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Shandong New Era Pharmaceutical Tegafur,Gimeracil and Oteracil Porassium Capsules Product
Table 89. Shandong New Era Pharmaceutical Recent Developments/Updates
Table 90. Yangtze River Pharmaceutical Group Company Information
Table 91. Yangtze River Pharmaceutical Group Description and Business Overview
Table 92. Yangtze River Pharmaceutical Group Tegafur,Gimeracil and Oteracil Porassium Capsules Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Yangtze River Pharmaceutical Group Tegafur,Gimeracil and Oteracil Porassium Capsules Product
Table 94. Yangtze River Pharmaceutical Group Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Tegafur,Gimeracil and Oteracil Porassium Capsules Distributors List
Table 98. Tegafur,Gimeracil and Oteracil Porassium Capsules Customers List
Table 99. Tegafur,Gimeracil and Oteracil Porassium Capsules Market Trends
Table 100. Tegafur,Gimeracil and Oteracil Porassium Capsules Market Drivers
Table 101. Tegafur,Gimeracil and Oteracil Porassium Capsules Market Challenges
Table 102. Tegafur,Gimeracil and Oteracil Porassium Capsules Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Product Picture of Tegafur,Gimeracil and Oteracil Porassium Capsules
Figure 2. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Share by Type: 2024 & 2031
Figure 4. 20mg Product Picture
Figure 5. 25mg Product Picture
Figure 6. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Value by Channel (2020-2031) & (US$ Million)
Figure 7. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Share by Channel: 2024 & 2031
Figure 8. Hospitals
Figure 9. Drug Stores
Figure 10. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size (2020-2031) & (US$ Million)
Figure 12. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Sales (2020-2031) & (M Units)
Figure 13. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Average Price (US$/Unit) & (2020-2031)
Figure 14. Tegafur,Gimeracil and Oteracil Porassium Capsules Report Years Considered
Figure 15. Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Share by Manufacturers in 2024
Figure 16. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Share by Manufacturers in 2024
Figure 17. Global 5 and 10 Largest Tegafur,Gimeracil and Oteracil Porassium Capsules Players: Market Share by Revenue in Tegafur,Gimeracil and Oteracil Porassium Capsules in 2024
Figure 18. Tegafur,Gimeracil and Oteracil Porassium Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 19. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 20. North America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Country (2020-2031)
Figure 21. North America Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Country (2020-2031)
Figure 22. United States Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 23. Canada Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Country (2020-2031)
Figure 25. Europe Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Country (2020-2031)
Figure 26. Germany Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. France Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. U.K. Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Italy Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Russia Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Asia Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Region (2020-2031)
Figure 32. Asia Pacific Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Region (2020-2031)
Figure 33. China Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Japan Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. South Korea Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. India Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Australia Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. China Taiwan Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Latin America Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Country (2020-2031)
Figure 41. Latin America Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Country (2020-2031)
Figure 42. Mexico Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Brazil Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Argentina Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Colombia Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Tegafur,Gimeracil and Oteracil Porassium Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Tegafur,Gimeracil and Oteracil Porassium Capsules by Type (2020-2031)
Figure 52. Global Revenue Market Share of Tegafur,Gimeracil and Oteracil Porassium Capsules by Type (2020-2031)
Figure 53. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Price (US$/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Tegafur,Gimeracil and Oteracil Porassium Capsules by Channel (2020-2031)
Figure 55. Global Revenue Market Share of Tegafur,Gimeracil and Oteracil Porassium Capsules by Channel (2020-2031)
Figure 56. Global Tegafur,Gimeracil and Oteracil Porassium Capsules Price (US$/Unit) by Channel (2020-2031)
Figure 57. Tegafur,Gimeracil and Oteracil Porassium Capsules Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
